Zimbabwe has declined a major US health deal valued at $367m (£272m) spanning five years because of Washington's insistence on sensitive biological samples.
The decision was revealed after a government memo dated December was leaked, revealing that President Emmerson Mnangagwa deemed the arrangement was "skewed".
A government spokesperson has since clarified that the United States was seeking health data for scientific study and profit but refused to guarantee the resulting advantages from future medical innovations.
"We must now begin the difficult and regrettable task of scaling back our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had provided more than $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged more dialogue to find a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.
Wider Background
This development follows a comparable situation in Kenya, where a court suspended a related health funding agreement following concerns were raised about the security of Kenyans' medical information.
After returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
The agency had managed aid for the American government, but Trump argued its expenditure was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.
Based on statements, Sixteen nations in Africa have so far signed these new agreements, representing more than $18.3bn in committed funds.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to share its genetic material and health information indefinitely, with no corresponding guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our people should a new health crisis arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending structures previously set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future global health emergencies.
"This framework is designed to ensure that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," he added.
"We welcome continued dialogue with our US partners on how subsequent collaboration might be arranged in a way that honours the sovereignty and interests of both nations."
Medical Community Reaction
A leading public health body said it understood the government's concerns, but suggested that talks need to persist considering much of the nation's HIV programmes were funded by foreign aid.
"If specific concerns exist, including those involving information security or implementation frameworks, these can often be resolved via detailed discussion and mutually agreed protections," it said.
This impasse highlights the ongoing challenges between accepting much-needed international aid and safeguarding a country's data in an ever more data-driven world.